Table 2.
Comorbidities and Treatment Adherence
| Molnupiravir Recipients | Νirmatrelvir/Ritonavir Recipients | |||
|---|---|---|---|---|
| No. | % | No. | % | |
| Comorbidity | ||||
| Obesity: BMI ≥35 kg/m2 | 435 | 10.26 | 2250 | 16.23 |
| Cardiovascular disease | 1964 | 46.32 | 9668 | 69.75 |
| Moderate-severe immunosuppression | 323 | 7.62 | 1209 | 8.72 |
| Type 2 diabetes mellitus | 808 | 19.06 | 3827 | 27.61 |
| Chronic disease | ||||
| Liver | 16 | 0.38 | 51 | 0.37 |
| Kidney | 239 | 5.64 | 598 | 4.31 |
| Lung | 201 | 4.74 | 1046 | 7.55 |
| Treatment adherence: No. of pills missed | ||||
| None | 3207 | 75.7 | 2626 | 19.0 |
| 0–5 | 353 | 8.3 | 308 | 2.2 |
| >5 to 12 | 92 | 2.2 | 141 | 1.0 |
| >12 but not all | 172 | 4.1 | 117 | 0.8 |
| All | 416 | 9.8 | 309 | 2.2 |
| Unknown | 0 | 0.0 | 10 360 | 74.7 |
Abbreviation: BMI, body mass index.